Global Rheumatoid Arthritis Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 89

Published Date: 02 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue) are used for rheumatoid arthritis stem cell therapy. As the rheumatoid arthritis worsens, the body initiates autoimmune response and attacks the cells. Rheumatoid arthritis stem cell therapy is growing in popularity across hospitals, ambulatory surgical centers, and specialty clinics, as it increases the healing of joints and further treats the entire system that causes the joint pain and inflammation.

According to our (Global Info Research) latest study, the global Rheumatoid Arthritis Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Rheumatoid Arthritis Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Rheumatoid Arthritis Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Rheumatoid Arthritis Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Rheumatoid Arthritis Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Rheumatoid Arthritis Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rheumatoid Arthritis Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rheumatoid Arthritis Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mesoblast, Roslin Cells, Regeneus, ReNeuron Group and International Stem Cell Corporation and  etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Rheumatoid Arthritis Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Allogeneic Mesenchymal Stem Cells
    Bone Marrow Transplant
    Adipose Tissue Stem Cells

Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics

Market segment by players, this report covers
    Mesoblast
    Roslin Cells
    Regeneus
    ReNeuron Group
    International Stem Cell Corporation
    Takeda

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rheumatoid Arthritis Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rheumatoid Arthritis Stem Cell Therapy, with revenue, gross margin and global market share of Rheumatoid Arthritis Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Rheumatoid Arthritis Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Rheumatoid Arthritis Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Rheumatoid Arthritis Stem Cell Therapy.
Chapter 13, to describe Rheumatoid Arthritis Stem Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Rheumatoid Arthritis Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Rheumatoid Arthritis Stem Cell Therapy by Type
        1.3.1 Overview: Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Allogeneic Mesenchymal Stem Cells
        1.3.4 Bone Marrow Transplant
        1.3.5 Adipose Tissue Stem Cells
    1.4 Global Rheumatoid Arthritis Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Specialty Clinics
    1.5 Global Rheumatoid Arthritis Stem Cell Therapy Market Size & Forecast
    1.6 Global Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Rheumatoid Arthritis Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Rheumatoid Arthritis Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Mesoblast
        2.1.1 Mesoblast Details
        2.1.2 Mesoblast Major Business
        2.1.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.1.4 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Mesoblast Recent Developments and Future Plans
    2.2 Roslin Cells
        2.2.1 Roslin Cells Details
        2.2.2 Roslin Cells Major Business
        2.2.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.2.4 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Roslin Cells Recent Developments and Future Plans
    2.3 Regeneus
        2.3.1 Regeneus Details
        2.3.2 Regeneus Major Business
        2.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.3.4 Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Regeneus Recent Developments and Future Plans
    2.4 ReNeuron Group
        2.4.1 ReNeuron Group Details
        2.4.2 ReNeuron Group Major Business
        2.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.4.4 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 ReNeuron Group Recent Developments and Future Plans
    2.5 International Stem Cell Corporation
        2.5.1 International Stem Cell Corporation Details
        2.5.2 International Stem Cell Corporation Major Business
        2.5.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.5.4 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 International Stem Cell Corporation Recent Developments and Future Plans
    2.6 Takeda
        2.6.1 Takeda Details
        2.6.2 Takeda Major Business
        2.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
        2.6.4 Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Rheumatoid Arthritis Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Rheumatoid Arthritis Stem Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 Rheumatoid Arthritis Stem Cell Therapy Players Market Share in 2022
    3.3 Rheumatoid Arthritis Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Rheumatoid Arthritis Stem Cell Therapy Market: Region Footprint
        3.3.2 Rheumatoid Arthritis Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Rheumatoid Arthritis Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
        6.3.1 North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
        7.3.1 Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
        9.3.1 South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Rheumatoid Arthritis Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Rheumatoid Arthritis Stem Cell Therapy Market Drivers
    11.2 Rheumatoid Arthritis Stem Cell Therapy Market Restraints
    11.3 Rheumatoid Arthritis Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Rheumatoid Arthritis Stem Cell Therapy Industry Chain
    12.2 Rheumatoid Arthritis Stem Cell Therapy Upstream Analysis
    12.3 Rheumatoid Arthritis Stem Cell Therapy Midstream Analysis
    12.4 Rheumatoid Arthritis Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Mesoblast Company Information, Head Office, and Major Competitors
    Table 6. Mesoblast Major Business
    Table 7. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 8. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Mesoblast Recent Developments and Future Plans
    Table 10. Roslin Cells Company Information, Head Office, and Major Competitors
    Table 11. Roslin Cells Major Business
    Table 12. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 13. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Roslin Cells Recent Developments and Future Plans
    Table 15. Regeneus Company Information, Head Office, and Major Competitors
    Table 16. Regeneus Major Business
    Table 17. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 18. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Regeneus Recent Developments and Future Plans
    Table 20. ReNeuron Group Company Information, Head Office, and Major Competitors
    Table 21. ReNeuron Group Major Business
    Table 22. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 23. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. ReNeuron Group Recent Developments and Future Plans
    Table 25. International Stem Cell Corporation Company Information, Head Office, and Major Competitors
    Table 26. International Stem Cell Corporation Major Business
    Table 27. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 28. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. International Stem Cell Corporation Recent Developments and Future Plans
    Table 30. Takeda Company Information, Head Office, and Major Competitors
    Table 31. Takeda Major Business
    Table 32. Takeda Rheumatoid Arthritis Stem Cell Therapy Product and Solutions
    Table 33. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Takeda Recent Developments and Future Plans
    Table 35. Global Rheumatoid Arthritis Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
    Table 36. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Players (2018-2023)
    Table 37. Breakdown of Rheumatoid Arthritis Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 38. Market Position of Players in Rheumatoid Arthritis Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 39. Head Office of Key Rheumatoid Arthritis Stem Cell Therapy Players
    Table 40. Rheumatoid Arthritis Stem Cell Therapy Market: Company Product Type Footprint
    Table 41. Rheumatoid Arthritis Stem Cell Therapy Market: Company Product Application Footprint
    Table 42. Rheumatoid Arthritis Stem Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 43. Rheumatoid Arthritis Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 44. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 45. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Table 46. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
    Table 47. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023)
    Table 48. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
    Table 49. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 50. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 51. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 52. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 53. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 54. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 55. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 56. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 57. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 58. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 59. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 60. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 61. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 62. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 63. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 64. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 65. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 66. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 67. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 68. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 69. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 70. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 71. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 72. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 73. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 74. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 75. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 76. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 77. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 78. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 79. Rheumatoid Arthritis Stem Cell Therapy Raw Material
    Table 80. Key Suppliers of Rheumatoid Arthritis Stem Cell Therapy Raw Materials
List of Figures
    Figure 1. Rheumatoid Arthritis Stem Cell Therapy Picture
    Figure 2. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Allogeneic Mesenchymal Stem Cells
    Figure 5. Bone Marrow Transplant
    Figure 6. Adipose Tissue Stem Cells
    Figure 7. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application in 2022
    Figure 9. Hospitals Picture
    Figure 10. Ambulatory Surgical Centers Picture
    Figure 11. Specialty Clinics Picture
    Figure 12. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Rheumatoid Arthritis Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Region in 2022
    Figure 17. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Players in 2022
    Figure 23. Rheumatoid Arthritis Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Rheumatoid Arthritis Stem Cell Therapy Market Share in 2022
    Figure 25. Global Top 6 Players Rheumatoid Arthritis Stem Cell Therapy Market Share in 2022
    Figure 26. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Figure 27. Global Rheumatoid Arthritis Stem Cell Therapy Market Share Forecast by Type (2024-2029)
    Figure 28. Global Rheumatoid Arthritis Stem Cell Therapy Consumption Value Share by Application (2018-2023)
    Figure 29. Global Rheumatoid Arthritis Stem Cell Therapy Market Share Forecast by Application (2024-2029)
    Figure 30. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Rheumatoid Arthritis Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Rheumatoid Arthritis Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 64. Rheumatoid Arthritis Stem Cell Therapy Market Drivers
    Figure 65. Rheumatoid Arthritis Stem Cell Therapy Market Restraints
    Figure 66. Rheumatoid Arthritis Stem Cell Therapy Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Stem Cell Therapy in 2022
    Figure 69. Manufacturing Process Analysis of Rheumatoid Arthritis Stem Cell Therapy
    Figure 70. Rheumatoid Arthritis Stem Cell Therapy Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Mesoblast
Roslin Cells
Regeneus
ReNeuron Group
International Stem Cell Corporation
Takeda

Related Reports

Global Rheumatoid Arthritis Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

Global Rheumatoid Arthritis Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

date 09 Feb 2023

date Pharma & Healthcare

The global Rheumatoid Arthritis Stem Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Rheumatoid Arthritis Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Rheumatoid Arthritis Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 13 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Rheumatoid Arthritis Stem Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Rheumatoid Arthritis Stem Cell Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>